DEA files final cannabis cultivation license rules (Newsletter: December 18, 2020)
Marijuana IndustryMarijuana Industry News December 18, 2020 0
VA gov’s budget funds legal marijuana prep; New Senate hemp bill; NY gov touts cannabis’s fiscal promise; Oakland OKs new psychedelics resolution Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.... Read more
Washington State Could Legalize Marijuana Home Cultivation Under New Bill
FeaturedMarijuana IndustryMarijuana Industry News December 18, 2020 0
New Jersey is one step closer to launching legal marijuana sales as approved by voters last month after the state Senate and Assembly passed landmark legislation Thursday to establish a framework for the new market. The proposal now heads to the desk of Gov. Phil Murphy (D) for his... Read more
Hemp’s 2 Year Anniversary: Looking back at the Top 10 milestones
FeaturedIndustrial Hemp NewsMarijuana Laws, Regulations, & Politics December 18, 2020 0
It’s been two years since low-THC cannabis known as hemp became legal after decades of prohibition in the United States. On Dec. 20, 2018, President Donald Trump signed the 2018 Farm Bill, an $867 billion measure that included seven little words that would forever change the entire cannabis industry:... Read more
Beckley Psytech announces USD $18m raise to conduct clinical trials on psychedelic medicine pipeline
December 18, 2020
Beckley Psytech, a psychedelic medicine company with deep ties to the historical Beckley Foundation, has raised USD $18m of new equity funding to develop psychedelic drugs into licensed pharmaceutical medicines for treating psychiatric and neurological diseases. New investors including Noetic Psychedelic Fund LP, a leading venture fund specializing in... Read more
Tryp Therapeutics Begins Trading on the Canadian Securities Exchange
December 18, 2020
Ryan Allway December 18th, 2020 Psychedelics, Top News La Jolla, CA – December 18, 2020 – Tryp Therapeutics Inc. (“Tryp” or the “Company”) (CSE: TRYP) is pleased to announce that the Company’s common shares have commenced trading on the Canadian Securities Exchange (“CSE”) under the symbol “TRYP” effective December 18, 2020.... Read more
Innovation zahlt sich aus bei Psychedelika
December 18, 2020
Es besteht ein erhebliches Interesse am psychedelischen Bereich und an den vielversprechenden psychedelischen Molekülen für die Behandlung von psychischen Erkrankungen. Geisteskrankheiten sind eine allgegenwärtige menschliche Erfahrung und eine bisher nur unzureichend behandelte medizinische Notwendigkeit. Psychedelika bieten eine Alternative zu unwirksamen Behandlungen, da sie über andere Wirkmechanismen funktionieren. Psychedelische Arzneimittel... Read more
Ryan Allway December 18th, 2020 App, Exclusive, News, Top News Charlotte’s Web Holdings Inc. (TSX: CWEB) bought Abacus Health Products Inc. in a stock transaction worth about $100 million last June. With competition on the rise in the CBD industry, Abacus provided Charlotte’s Web with a portfolio of over-the-counter... Read more
Innovation Pays Off in Psychedelics
December 18, 2020
Ryan Allway December 18th, 2020 App, Exclusive, Psychedelics, Top Story There has been significant interest in the psychedelic space and of the promise psychedelic molecules show in treating mental health conditions. Mental illness is a ubiquitous human experience and an insufficiently addressed medical necessity. Psychedelics offer an alternative to... Read more
